Status:
RECRUITING
Biologic Augment of the Medial Patellofemoral Ligament Following Primary Lateral Patellofemoral Dislocation (BioPPD)
Lead Sponsor:
Banff Sport Medicine Foundation
Collaborating Sponsors:
CONMED Corporation
Conditions:
Patellofemoral Dislocation
Eligibility:
All Genders
13-30 years
Phase:
NA
Brief Summary
This study aims to determine the ability of medial patellofemoral ligament (MPFL) repair augmented with Biobrace® to decrease the re-dislocation rate after a primary patellofemoral dislocation. First-...
Detailed Description
This study aims to determine the ability of MPFL repair augmented with Biobrace® to decrease the re-dislocation rate after a primary patellofemoral dislocation. The null hypothesis is that there will ...
Eligibility Criteria
Inclusion
- Age 13 - 30 years
- First-time lateral patellofemoral dislocation in the previous 7 days
- Closed or closing growth plates (confirmed on knee x-rays with no change required for surgical technique)
Exclusion
- History of previous patellofemoral dislocation on the index knee
- An osteochondral fracture of the patellofemoral joint that requires surgical repair
- Unable to complete computer-based outcome questionnaires
- Pregnant at the time of surgery
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06169800
Start Date
January 15 2024
End Date
June 30 2027
Last Update
October 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Banff Sport Medicine
Canmore, Alberta, Canada, T1W 0L5